The high expenditure on medicines, even when there is a co-payment, can pose a risk to the health of citizens. What pharmaceutical reimbursement policies can guarantee that no one is left without the medicines we need? How do European governments ensure pharmaceutical coverage? How do they protect the most vulnerable population? In this webinar you will learn about the European experience and the strategies they seek to protect the most vulnerable population from excessive spending on medicines.